Publication | Closed Access

Safety and immunogenicity of the tau vaccine AADvac1 in patients with Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase 1 trial

VaccinationAlzheimer's DiseaseVaccine DevelopmentDementiaImmunologyVaccine EfficacyAging-associated DiseaseTau Vaccine Aadvac1MedicineVaccine ResearchProtective MechanismsHealth Sciences